Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feng Cai

Showing results (871-880 of 908) with videos related to

Pageof 91
Sort By:
Cell Metabolism|August 23, 2023
Comprehensive isotopomer analysis of glutamate and aspartate in small tissue samplesFeng Cai, Divya Bezwada, Ling Cai, et al.
The Lancet. Respiratory Medicine|March 10, 2023
Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trialRong Tang, Hui Zheng, Bu-Sen Wang, et al.
Lancet (London, England)|August 24, 2010
Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trialFeng-Cai Zhu, Jun Zhang, Xue-Feng Zhang, et al.
The Lancet Regional Health. Western Pacific|June 7, 2023
Safety and immunogenicity of an Kai Chu, Zhao-Feng Bi, Wei-Jin Huang, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|July 8, 2026
Regulation of tumorigenesis by cellular senescence: Mechanisms and pathways in liver cancer and cholangiocarcinomaTao Lu, Si-Yi Zou, Chang-Sheng Dong, et al.
Ebiomedicine|April 26, 2023
Safety and immunogenicity of a modified COVID-19 mRNA vaccine, SW-BIC-213, as a heterologous booster in healthy adults: an open-labeled, two-centered and multi-arm randomised, phase 1 trialYu-Zhou Gui, Xue-Ning Li, Jing-Xin Li, et al.
The New England Journal of Medicine|March 5, 2015
Long-term efficacy of a hepatitis E vaccineJun Zhang, Xue-Feng Zhang, Shou-Jie Huang, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
An interactive web application for exploring human plasma and fibroblast metabolomics data from patients with inborn errors of metabolismLing Cai, Hieu S Vu, Wen Gu, et al.
Cell Metabolism|June 14, 2024
Electron transport chain inhibition increases cellular dependence on purine transport and salvageZheng Wu, Divya Bezwada, Feng Cai, et al.
The Lancet Regional Health. Western Pacific|June 26, 2023
Immunogenicity and safety of heterologous immunisation with Ad5-nCOV in healthy adults aged 60 years and older primed with an inactivated SARS-CoV-2 vaccine (CoronaVac): a phase 4, randomised, observer-blind, non-inferiority trialPeng-Fei Jin, Xi-Ling Guo, Jin-Bo Gou, et al.
Pageof 91

Showing results (871-880 of 908) with videos related to

Sort By:
Pageof 91
Cell Metabolism|August 23, 2023
Comprehensive isotopomer analysis of glutamate and aspartate in small tissue samplesFeng Cai, Divya Bezwada, Ling Cai, et al.
The Lancet. Respiratory Medicine|March 10, 2023
Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trialRong Tang, Hui Zheng, Bu-Sen Wang, et al.
Lancet (London, England)|August 24, 2010
Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trialFeng-Cai Zhu, Jun Zhang, Xue-Feng Zhang, et al.
The Lancet Regional Health. Western Pacific|June 7, 2023
Safety and immunogenicity of an Kai Chu, Zhao-Feng Bi, Wei-Jin Huang, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|July 8, 2026
Regulation of tumorigenesis by cellular senescence: Mechanisms and pathways in liver cancer and cholangiocarcinomaTao Lu, Si-Yi Zou, Chang-Sheng Dong, et al.
Ebiomedicine|April 26, 2023
Safety and immunogenicity of a modified COVID-19 mRNA vaccine, SW-BIC-213, as a heterologous booster in healthy adults: an open-labeled, two-centered and multi-arm randomised, phase 1 trialYu-Zhou Gui, Xue-Ning Li, Jing-Xin Li, et al.
The New England Journal of Medicine|March 5, 2015
Long-term efficacy of a hepatitis E vaccineJun Zhang, Xue-Feng Zhang, Shou-Jie Huang, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
An interactive web application for exploring human plasma and fibroblast metabolomics data from patients with inborn errors of metabolismLing Cai, Hieu S Vu, Wen Gu, et al.
Cell Metabolism|June 14, 2024
Electron transport chain inhibition increases cellular dependence on purine transport and salvageZheng Wu, Divya Bezwada, Feng Cai, et al.
The Lancet Regional Health. Western Pacific|June 26, 2023
Immunogenicity and safety of heterologous immunisation with Ad5-nCOV in healthy adults aged 60 years and older primed with an inactivated SARS-CoV-2 vaccine (CoronaVac): a phase 4, randomised, observer-blind, non-inferiority trialPeng-Fei Jin, Xi-Ling Guo, Jin-Bo Gou, et al.
Pageof 91